Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
US-12121499-B2 · Oct 22, 2024 · US
This page is not indexed by search engines while we improve data quality.
Stephens Gary patents
Stephens Gary is listed as an inventor on 21 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Stephens Gary |
| Total patents | 21 |
| First publication | Jun 30, 2015 |
| Latest publication | Oct 22, 2024 |
Notable patents
Publications ranked by popularity score, then publication date.
Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy
US-12023305-B2 · Jul 2, 2024 · US
7-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in the treatment of epilepsy
US-11793770-B2 · Oct 24, 2023 · US
Use of the phytocannabinoid cannabidiol (cbd) in combination with a standard anti-epileptic drug (saed) in the treatment of epilepsy
US-2022395470-A1 · Dec 15, 2022 · US
Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (cbdv) and cannabidiol (cbd)
US-2022387347-A1 · Dec 8, 2022 · US
Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
US-11318109-B2 · May 3, 2022 · US
7-oh-cannabidiol (7-oh-cbd) and/or 7-oh-cannabidivarin (7-oh-cbdv) for use in the treatment of epilepsy
US-2022062197-A1 · Mar 3, 2022 · US
7-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in the treatment of epilepsy
US-11147776-B2 · Oct 19, 2021 · US
Use of the phytocannabinoid cannabidivarin (cbdv) in the treatment of epilepsy
US-2021100755-A1 · Apr 8, 2021 · US
Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy
US-10799467-B2 · Oct 13, 2020 · US
Recent patents
Latest publications not already listed above.
Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
US-10729665-B2 · Aug 4, 2020 · US
7-oh-cannabidiol (7-oh-cbd) and/or 7-oh-cannabidivarin (7-oh-cbdv) for use in the treatment of epilepsy
US-2020206152-A1 · Jul 2, 2020 · US
Pharmaceutical Composition Comprising the Phytocannabinoids Cannabidivarin (CBDV) and Cannabidiol (CBD)
US-2020108027-A1 · Apr 9, 2020 · US
One or a Combination of Phyto-Cannabinoids in the Treatment of Epilepsy
US-2019247324-A1 · Aug 15, 2019 · US
Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy
US-2017273913-A1 · Sep 28, 2017 · US
7-oh-cannabidiol (7-oh-cbd) and/or 7-oh-cannabidivarin (7-oh-cbdv) for use in the treatment of epilepsy
US-2017209390-A1 · Jul 27, 2017 · US
Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy
US-9522123-B2 · Dec 20, 2016 · US
Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy
US-2015335590-A1 · Nov 26, 2015 · US
Use of the phytocannabinoid cannabidivarin (cbdv) in the treatment of epilepsy
US-2015320698-A1 · Nov 12, 2015 · US
Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy
US-9125859-B2 · Sep 8, 2015 · US
Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy
US-9066920-B2 · Jun 30, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Gw Pharma Ltd | 17 |
| Otsuka Pharma Co Ltd | 13 |
| Gw Res Ltd | 4 |
| Williams Claire | 3 |
| Stephens Gary | 3 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K31/658 | 21 |
| A61P25/08 | 21 |
| A61K31/05 | 21 |
| A61K45/06 | 16 |
| A61K36/3482 | 15 |